RTI-336

N/A

Report date: 2022/06/20 11:05:11
NME

Base Information

Drug NameRTI-336
Drug Alias NameRTI-336RTI-4229-336
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine transporter antagonists
TargetsDopamine transporter
Therapy Area/IndicationsCocaine-Related DisordersSubstance-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesResearch Triangle Inst
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCocaine-Related DisordersSubstance-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A